Rimonabant er en selektiv cannabinoid- 1 receptor (CB1) antagonist som hæmmer den farmakologiske effekt af cannabinoid agonister in vitro og in vivo.
Rimonabant is a selective cannabinoid-1 receptor (CB1) antagonist that inhibits the pharmacological effects of cannabinoid agonists in vitro and in vivo.